News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Leading breast cancer researcher elected as Fellow of the Academy of Medical Sciences
Professor Nicholas Turner has been recognised with a prestigious Fellowship of the Academy of Medical Sciences for his excellence in breast cancer research and outstanding contribution to the field.
Ovarian cancer drug offers new genetically targeted approach against range of cancers
A type of drug used against ovarian and breast cancers could offer a brand new targeted approach for treating a range of cancers with particular genetic defects, including a common form of kidney cancer.
Three-drug combination moves forward for advanced breast cancer
A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows.
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer
An already approved breast cancer drug could bring hope to thousands of UK women who have an aggressive form of breast cancer, new research has found.
Scientific achievements of 2020
We've selected a range of discoveries from 2019/20 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
Major ‘plasmaMATCH’ trial uses blood test to match women with breast cancer to range of precision treatments
A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.
Immune system could be trained to spot drug-resistant cancers
Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests.
Scientific achievements of 2019
We've selected a range of discoveries from 2018/19 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
New test predicts chance of living more than a year on targeted breast cancer treatment
A new test could pick out women with advanced breast cancer who are likely to benefit from an exciting new targeted therapy for more than a year.
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy
The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted cancer treatment palbociclib for women with advanced breast cancer who have already received hormone therapy.
How ICR researchers are leading the way in breast cancer research
In Breast Cancer Awareness Month, Rose Wu looks at some of the recent research breakthroughs by breast cancer researchers at the ICR
New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
